ARA-290
ARA-290 is a synthetic peptide derived from erythropoietin studied for its interaction with tissue-protective receptor signaling pathways [1,2].
This peptide is for research purposes only. Not for human consumption.
Description
EPO Receptor Signaling
ARA-290 selectively engages the innate repair receptor associated with erythropoietin signaling [1].
Cellular Stress and Repair Models
Studies explore its role in cellular stress response, inflammation modulation, and protective signaling pathways [2].
Peptide Design Rationale
As a non-erythropoietic fragment, ARA-290 allows focused study of protective signaling independent of hematopoiesis [1].
Key Specs
• Peptide class: EPO-derived fragment
• Research context: tissue-protective signaling
• References: PubMed [1,2]
Referenced Citations
- PubMed, ARA-290 and EPO receptor signaling: https://pubmed.ncbi.nlm.nih.gov/22473924/
- PubMed, Innate repair receptor pathways: https://pubmed.ncbi.nlm.nih.gov/23921148/
EPO Receptor Signaling
ARA-290 selectively engages the innate repair receptor associated with erythropoietin signaling [1].
Cellular Stress and Repair Models
Studies explore its role in cellular stress response, inflammation modulation, and protective signaling pathways [2].
Peptide Design Rationale
As a non-erythropoietic fragment, ARA-290 allows focused study of protective signaling independent of hematopoiesis [1].
Key Specs
• Peptide class: EPO-derived fragment
• Research context: tissue-protective signaling
• References: PubMed [1,2]
Referenced Citations
- PubMed, ARA-290 and EPO receptor signaling: https://pubmed.ncbi.nlm.nih.gov/22473924/
- PubMed, Innate repair receptor pathways: https://pubmed.ncbi.nlm.nih.gov/23921148/
Reviews
There are no reviews yet.